EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

ITGA2B / ITGB3 ‐Related Macrothrombocytopenia Associated With Gain‐of‐Function Mutations in ITGA2B or ITGB3 Genes

Jiao Wu, Han Yan, Zijian Li, Yilin Zhu, Ruonan Shao, Honglei Xin, Tongyu Jia, Mengyu Ge, Lu Zhang, Suyu Jiang, Jianhua Mao, Jiansong Huang iD und 3 weitere

Journal of Cellular and Molecular Medicine · 2026

DOI: 10.1111/jcmm.70988 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Cellular and Molecular Medicine, 2026. Verfasst von Jiao Wu und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hematology, The Second Affiliated Hospital of Nanjing Medical University, Nanjing, China. Hauptthemen laut MEDLINE: Integrin alpha2, Thrombocytopenia, Integrin beta3, Gain of Function Mutation. Die Arbeit nennt 60 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, The Science and Technology Commission of Shanghai Municipality, NHC Key Laboratory of Thrombosis and Hemostasis, the First Affiliated Hospital of Soochow University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Glanzmann thrombasthenia (GT) is an inherited hemorrhagic disorder characterised by impaired platelet functions, manifested clinically as spontaneous bleeding. It is usually inherited in an autosomal recessive manner. Platelet dysfunction in patients with GT is caused by quantitative and/or qualitative deficiencies in αIIbβ3, which result from mutations in the genes encoding αIIbβ3. These genetic alterations lead to platelet dysfunction characterised by impaired fibrinogen binding capacity upon agonist stimulation, defective aggregation and spreading. While classical GT typically exhibits normal platelet counts and morphology, very rare mutations in ITGA2B ( encoding αIIb) and/or ITGB3 ( encoding β3) cause macrothrombocytopenia or increased platelet anisotropy (heterogeneity of platelet size and morphology). This type of mutation mainly localises in the membrane‐proximal region of αIIbβ3 and is inherited in an autosomal dominant manner. This particular type of disorder is called ITGA2B / ITGB3 ‐related macrothrombocytopenia and has been considered a subset of congenital macrothrombocytopenia. Current research suggests that gain‐of‐function mutations in ITGA2B or ITGB3 underlie the pathogenesis of most ITGA2B / ITGB3 ‐related macrothrombocytopenia and mechanistically distinguish it from classical GT. However, recent reports have documented non‐activating ITGB3 mutations that also cause macrothrombocytopenia, presenting a profound challenge to the mechanistic understanding of ITGA2B/ITGB3 ‐related macrothrombocytopenia. This review summarises the reported cases of gain‐of‐function mutations in ITGA2B and ITGB3 associated with ITGA2B / ITGB3 ‐related macrothrombocytopenia hitherto and discusses the potential molecular pathways contributing to the unique phenotypes in ITGA2B / ITGB3 ‐related macrothrombocytopenia.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Integrin alpha2ThrombocytopeniaIntegrin beta3Gain of Function MutationHumansBlood PlateletsThrombastheniaAnimalsPlatelet Glycoprotein GPIIb-IIIa Complex

Stichwörter der Autor:innen

Glanzmann thrombastheniagain‐of‐function mutationintegrin αIIbβ3macrothrombocytopeniaplatelet disorder

Substanzen

Integrin alpha2Integrin beta3ITGA2B protein, humanITGB3 protein, humanPlatelet Glycoprotein GPIIb-IIIa Complex

Autor:innen und Institutionen

  • Department of Hematology, The Second Affiliated Hospital of Nanjing Medical University, Nanjing, China.
  • Department of Hematology, Chifeng Municipal Hospital, Chifeng, China.
  • Shanghai Institute of Hematology, State Key Laboratory of Medical Genomics, National Research Center for Translational Medicine at Shanghai, Collaborative Innovation Center of Hematology, Ruijin Hospital, Shanghai Jiao…
  • Department of Hematology, Zhejiang Key Laboratory for Precision Diagnosis and Treatment of Hematological Malignancies, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China.
  • Department of Pharmacology, School of Basic Medicine, Tongji Medical College and State Key Laboratory for Diagnosis and Treatment of Severe Zoonotic Infectious Diseases, Huazhong University of Science and Technology, Wu…
  • The Key Laboratory for Drug Target Researches and Pharmacodynamic Evaluation of Hubei Province and Tongji-Rongcheng Center for Biomedicine, Huazhong University of Science and Technology, Wuhan, Hubei, China.

ORCID-Profile: Jiansong Huang, Chao Fang, Xiaofeng Shi

Förderung

  • National Natural Science Foundation of China
  • The Science and Technology Commission of Shanghai Municipality
  • NHC Key Laboratory of Thrombosis and Hemostasis, the First Affiliated Hospital of Soochow University
  • The Natural Science Fund for Distinguished Young Scholars of Hubei Province
  • The Undergraduate Teaching and Research Project of Huazhong University of Science and Technology
  • The Graduate Teaching and Research Project of Huazhong University of Science and Technology
  • the National Natural Science Foundation of China
  • Science and Technology Commission of Shanghai Municipality

Zitieren

APA

Wu, J., Yan, H., Li, Z., Zhu, Y., Shao, R., Xin, H., Jia, T., Ge, M., Zhang, L., Jiang, S., Mao, J., Huang, J., Fang, C., Xi, X., & Shi, X. (2026). ITGA2B / ITGB3 ‐Related Macrothrombocytopenia Associated With Gain‐of‐Function Mutations in ITGA2B or ITGB3 Genes. Journal of Cellular and Molecular Medicine. https://doi.org/10.1111/jcmm.70988

Vancouver

Wu J, Yan H, Li Z, Zhu Y, Shao R, Xin H, et al. ITGA2B / ITGB3 ‐Related Macrothrombocytopenia Associated With Gain‐of‐Function Mutations in ITGA2B or ITGB3 Genes. Journal of Cellular and Molecular Medicine. 2026. doi:10.1111/jcmm.70988

BibTeX
@article{Wu2026,
  author = {Wu, Jiao and Yan, Han and Li, Zijian and Zhu, Yilin and Shao, Ruonan and Xin, Honglei and Jia, Tongyu and Ge, Mengyu and Zhang, Lu and Jiang, Suyu and Mao, Jianhua and Huang, Jiansong and Fang, Chao and Xi, Xiaodong and Shi, Xiaofeng},
  title = {ITGA2B / ITGB3 ‐Related Macrothrombocytopenia Associated With Gain‐of‐Function Mutations in ITGA2B or ITGB3 Genes},
  journal = {Journal of Cellular and Molecular Medicine},
  year = {2026},
  doi = {10.1111/jcmm.70988}
}
Kostenlos starten →